Skip to main content

Discoid Lupus

  • Reference work entry
  • First Online:
Encyclopedia of Medical Immunology
  • 495 Accesses

Synonyms

Chronic cutaneous lupus; Cutaneous only lupus; Skin lupus

Definition

Discoid lupus (DLE) is a chronic, scarring skin disease characterized by clinical, histologic, and immunopathologic findings, commonly on the face over the cheeks and bridge of the nose in a “malar” or “butterfly” distribution.

Skin disease is the second most common clinical manifestation of lupus, after joint inflammation, and is divided into acute, subacute, and chronic cutaneous forms. Of the chronic cutaneous forms, discoid lupus is the most characteristic with prominence on the face, ears, and scalp.

These “discoid” or coin-shaped lesions frequently progress to permanent scars with significant effect on the quality of life in those individuals with the disease, suggesting that prevention as well as early and efficient management towards remission be the goal of the treating physician. There are variants of DLE including the hypertrophic or lichen planus overlap form as well as the palmar/plantar or acral...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 799.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 949.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Akanase A, Reddy A, Buyon JP, Franks AG Jr, Furie RA, Kamen DL, Manzi S, Petri M, Ramsey-Goldman R, Tseng C-E, van Vollenhoven RF, Wallace DJ. Favorable Clinical Response to Belimumab at Three Months. Arthritis & Rheumatism. 2013;65(S10):S668–S668.

    Google Scholar 

  • Albrecht J, Taylor L, Berlin JA, Dulay S, Ang G, Fakharzadeh S, Kantor J, Kim E, Militello G, McGinnis K, Richardson S, Treat J, Vittorio C, Van Voorhees A, Werth VP. The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus. J Invest Dermatol. 2005;125(5):889–94.

    PubMed  CAS  PubMed Central  Google Scholar 

  • Bastuji-Garin S, Ochonisky S, Bouche P, Gherardi RK, Duguet C, Djerradine Z, Poli F, Djerradine J, Thalidomide Neuropathy Study Group. Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients. J Invest Dermatol. 2002;119(5):1020–6.

    PubMed  CAS  Google Scholar 

  • Berger E, Robinson M, Patel R, Franks Jr AG. Koebner phenomenon to heat in cutaneous (discoid) lupus erythematosus (lupus ab-igne). Dermatol Online J. 2012;18(12):17.

    PubMed  Google Scholar 

  • Braunstein I, Klein R, Okawa J, Werth VP. The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score. Br J Dermatol. 2012;166(5):971–5.

    PubMed  CAS  PubMed Central  Google Scholar 

  • Chong BF, Song J, Olsen NJ. Determining risk factors for developing systemic lupus erythematosus in patients with discoid lupus erythematosus. Br J Dermatol. 2012;166(1):29–35.

    PubMed  CAS  Google Scholar 

  • Costedoat-Chalumeau N, Galicier L, Aumaître O, Francès C, Le Guern V, Lioté F, Smail A, Limal N, Perard L, Desmurs-Clavel H, Boutin DL, Asli B, Kahn JE, Pourrat J, Sailler L, Ackermann F, Papo T, Sacré K, Fain O, Stirnemann J, Cacoub P, Jallouli M, Leroux G, Cohen-Bittan J, Tanguy ML, Hulot JS, Lechat P, Musset L, Amoura Z, Piette JC; on behalf of Group PLUS. Hydroxychloroquine in systemic lupus erythematosus: results of a French multicenter controlled trial (PLUS Study)controlled trial (PLUS) Ann Rheum Dis. 2013;72(11):1786–92.

    Google Scholar 

  • Cuadrado MJ, Karim Y, Sanna G, Smith E, Khamashta MA, Hughes GR. Thalidomide for the treatment of resistant cutaneous lupus: efficacy and safety of different therapeutic regimens. Am J Med. 2005;118(3):246–50.

    PubMed  CAS  Google Scholar 

  • DeSouza A, Strober BE, Merola JF, Oliver S, Franks Jr AG. Apremilast for discoid lupus erythematosus: results of a phase 2, open-label, single-arm, pilot study. J Drugs Dermatol. 2012;11(10):1224–6.

    CAS  Google Scholar 

  • De Souza A, Ali-Shaw T, Strober BE, Franks Jr AG. Successful treatment of subacute lupus erythematosus with ustekinumab. Arch Dermatol. 2011;147(8):896–8.

    PubMed  Google Scholar 

  • Erceg A, Bovenschen HJ, van de Kerkhof PC, et al. Efficacy and safety of pulsed dye laser treatment for cutaneous discoid lupus erythematosus. J Am Acad Dermatol. 2009;60:626–32.

    PubMed  Google Scholar 

  • Franks AG. Ask the experts: is the use of laser safe for people with lupus. Lupus Now. 2004;FALL:32–3.

    Google Scholar 

  • Jabbari A, Suarez-Farinas M, Fuentes-Duculan J, Gonzalez J, Cueto I, Franks AG Jr, Krueger JG. J Invest Dermatol. 2014;134:87–95.

    PubMed  CAS  Google Scholar 

  • Järvinen TM, Hellquist A, Koskenmies S, Einarsdottir E, Panelius J, Hasan T, Julkunen H, Padyukov L, Kvarnström M, Wahren-Herlenius M, Nyberg F, D'Amato M, Kere J, Saarialho-Kere U. Polymorphisms of the ITGAM gene confer higher risk of discoid cutaneous than of systemic lupus erythematosus. PLoS One. 2010;2:5(12).

    Google Scholar 

  • Jemec GB, Ullman S, Goodfield M, et al. A randomized controlled trial of R-salbutamol for topical treatment of discoid lupus erythematosus. Br J Dermatol. 2009;161:1365–70.

    PubMed  CAS  Google Scholar 

  • Jessop S, Whitelaw DA, Delamere FM. Drugs for discoid lupus erythematosus. Cochrane Database Syst Rev. 2009;7(4):CD002954.

    Google Scholar 

  • Lin JH, Dutz JP, Sontheimer RD, Werth VP. Pathophysiology of cutaneous lupus erythematosus. Clin Rev Allergy Immunol. 2007;33:85–106.

    PubMed  CAS  Google Scholar 

  • Makol A, Gibson LE, Michet CJ. Successful use of interleukin 6 antagonist tocilizumab in a patient with refractory cutaneous lupus and urticarial vasculitis. J Clin Rheumatol. 2012;18:92–5.

    PubMed  Google Scholar 

  • Merola JF, Chang CA, Sanchez MR, Prystowsky SD. Is chronic cutaneous discoid lupus protective against severe renal disease in patients with systemic lupus erythematosus? J Drugs Dermatol. 2011;10(12):1413–20.

    PubMed  CAS  Google Scholar 

  • Nabatian et al. Tumor necrosis factor a release in peripheral blood mononuclear cells of cutaneous lupus and dermatomyositis patients. Arthritis Res Ther. 2012;14(1):R1.

    Google Scholar 

  • Piette JC, Sbai A, Francès C. Warning: thalidomide-related thrombotic risk potentially concerns patients with lupus. Lupus. 2002;11(2):67–70.

    PubMed  CAS  Google Scholar 

  • Vasquez R, Tseng LC, Victor S, Zhang S, Chong BF. Autoantibody and clinical profiles in patients with discoid lupus and borderline systemic lupus. Arch Dermatol. 2012;148(5):651–5.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrew G. Franks Jr. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this entry

Cite this entry

Franks, A.G. (2014). Discoid Lupus. In: Mackay, I.R., Rose, N.R., Diamond, B., Davidson, A. (eds) Encyclopedia of Medical Immunology. Springer, New York, NY. https://doi.org/10.1007/978-0-387-84828-0_280

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-84828-0_280

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-84827-3

  • Online ISBN: 978-0-387-84828-0

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics